Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency.

Timm GreulichFrancisco Rodríguez-FriasIrene BelmonteAndreas KlemmerClaus F VogelmeierMarc Miravitlles

Published in: Respiratory research (2018)

The tested device can be used as an appropriate tool to exclude AATD in primary care and in the overall COPD population, except in patients with a high a-priori- probability of AATD.

Keyphrases

primary care
chronic obstructive pulmonary disease
high throughput
loop mediated isothermal amplification
lung function
real time pcr
label free
general practice
replacement therapy
cystic fibrosis
smoking cessation
single cell